19 completed, 10 unknown, 3 recruiting, 1 withdrawn. 33 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 33 | Completed 19, Unknown 10, Recruiting 3, Withdrawn 1 |
Follow Tadalafil: new trials by email Literature Review of Tadalafil trials Research Report on Tadalafil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH Tamsulosin 0.4 mg + Tadalafil 2.5 mg, Tamsulosin 0.4 mg + Tadalafil 5 mg, Tamsulosin 0.4 mg - Safety, Efficacy | Not applicable | Recruiting | Ain Shams University | 90 | 2026-07-01 | 2026-07-23 |
| Dorsal Penile Nerve Cryoneurolysis for Lifelong PE Percutaneous Dorsal Penile Nerve Cryoneurolysis, Sertraline (Oral Antidepressant), Tadalafil 5 mg - Premature Ejaculation | Not applicable | Completed | Biruni University | 117 | 2026-02-04 | 2026-10-16 |
| Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg Tamsulosin - Kidney Stone, Ureteric Stone | Not applicable | Recruiting | Ain Shams University | 140 | 2025-12-01 | 2026-05-01 |
| Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot Tadalafil - Diabetic Foot, Wound Healing Delayed | Not applicable | Completed | Deraya University | 1 | 2025-09-01 | 2026-08-20 |
| Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females Solifenacin, Tadalafil - Overactive Bladder | Not applicable | Completed | Ain Shams University | 80 | 2025-05-15 | 2025-12-31 |
| Comparison of Sequential to Initial Combination Therapy in PAH Tadalafil, Ambrisentan, Ambrisentan mimic - Pulmonary Arterial Hypertension (PAH) | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 376 | 2025-05-14 | 2025-07-29 |
| Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction Tadalafil 5mg, LIPUS (Low Intensity Pulsed Ultrasound) - Erectile Dysfunction | Not applicable | Completed | Second Affiliated Hospital, Zhejiang University, School of Medicine | 114 | 2024-08-11 | 2025-03-10 |
| The Effects of a Nitrate Supplementation on Erectile Function Nitric Oxide, Tadalafil, Placebo - Erectile Dysfunction | Not applicable | Unknown | RHA Investments Ltd | 20 | 2023-12-12 | 2024-01-19 |
| Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy. Tadalafil (PDE5i) - Erectile Dysfunction | Not applicable | Unknown | Regina Elena Cancer Institute | 158 | 2023-09-15 | 2024-06-04 |
| Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension tadalafil 20 mg then 40 mg if tolerated - Group 2 Pulmonary Hypertension, CpcPH | Not applicable | Completed | Beni-Suef University | 66 | 2023-03-10 | 2026-08-11 |
| Efficacy and Safety of Focused Shockwave Therapy Plus Tadalafil vs Tadalafil Alone in Patient With Erectile Dysfunction PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil) - Erectile Dysfunction | Not applicable | Unknown | Saint Petersburg State University, Russia | 36 | 2023-02-01 | 2023-05-06 |
| Management of OAB in Female Patients . Solfenacin, Mirabegron, Tadalafil 5mg - Overactive Bladder | Not applicable | Completed | Elsayed Abdelhalim Elsayed | 300 | 2022-09-14 | 2024-04-02 |
| Early Postoperative Triple Targeted Therapy in Patients With CHD-PAH in the "Grey Zone" Control group (ambrisentan plus tadalafil or macitentan plus tadalafil), Treatment group (ambrisentan plus tadalafil plus treprostinil or macitentan plus tadalafil plus treprostinil) - Congenital Heart Disease, Pulmonary Hypertension | Not applicable | Completed | China National Center for Cardiovascular Diseases | 30 | 2022-08-25 | 2026-09-28 |
| (Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and Phosphodiesterase 5 Inhibitors - Benign Prostatic Hyperplasia | Not applicable | Unknown | Assiut University | 120 | 2022-05-01 | 2022-02-11 |
| Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones Placebo, Silodosin, Tadalafil - Lower Ureteric Stones, Medical Expulsive Therapy | Not applicable | Completed | Benha University | 168 | 2022-03-30 | 2023-03-31 |
| Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms Tadalafil 5mg - Lower Urinary Tract Symptoms | Not applicable | Unknown | Mansoura University | 80 | 2022-01-01 | 2022-01-11 |
| Shock Wave vs. On-demand Tadalafil for Erectile Dysfunction LI-ESWT, Tadalafil 20Mg Oral Tablet - Erectile Dysfunction | Not applicable | Unknown | Menoufia University | 50 | 2021-09-01 | 2022-01-20 |
| Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment Endocan, tadalafil - Erectile Dysfunction | Not applicable | Unknown | Ankara Training and Research Hospital | 90 | 2021-06-24 | 2021-11-05 |
| Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction Tadalafil 5Mg Tab + continuous and interval exercise, Tadalafil 5Mg Tab - Erectile Dysfunction | Not applicable | Unknown | Cairo University | 60 | 2020-10-12 | 2020-11-10 |
| The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction Li-ESWT, Tadalafil 2.5Mg Tab - Erectile Dysfunction | Not applicable | Completed | Dr. Soetomo General Hospital | 30 | 2019-12-10 | 2021-09-14 |
Showing 20 of 33. Sign in to see all of them.
Erectile Dysfunction (12) · Diabetes Mellitus (2) · Lower Urinary Tract Symptoms (2) · Prostatic Hyperplasia (2) · Urinary Bladder, Overactive (2) · Altitude Sickness (1) · Brain Edema (1) · Diabetic Foot (1) · Fatigue (1) · Fibrosis (1) · Head and Neck Neoplasms (1) · Heart Defects, Congenital (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Kidney Calculi (1)
Ain Shams University (3) · Institute for the Study of Urological Diseases, Greece (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Adrian Gaspar (1) · Ankara Training and Research Hospital (1) · Assiut University (1) · Aswan University Hospital (1) · Benha University (1) · Beni-Suef University (1) · Biruni University (1) · Cairo University (1) · China National Center for Cardiovascular Diseases (1) · Deraya University (1) · Donald T. Weed (1) · Dr. Soetomo General Hospital (1)
Egypt (11) · United States (4) · China (3) · Greece (2) · Turkey (Türkiye) (2) · Argentina (1) · Brazil (1) · Denmark (1) · India (1) · Indonesia (1) · Israel (1) · Italy (1) · Russia (1) · United Kingdom (1)
Dimitrios Hatzichristou, Prof. (2) · Ali Ismail, lecturer (1) · Amr A Elsawy (1) · Anne Laumann, MBChB, MRCP (1) · Bodong Lv, MD (1) · Donald T. Weed, MD (1) · Heitor Moreno-Junior, MD, PhD (1) · Lars C Laursen, MD (1) · Melinda Sheffield-Moore, PhD (1) · Mohamed E Osman, MD (1) · Morris J Brown (1) · Moustafa M El Taieb, MD (1) · Nancy J Brown, M.D. (1) · Steven Bauer (1)
PMID 22943271, PMID 25320361, PMID 34775577, PMID 37929840, PMID 41291823
2009 (1)